Human immunodeficiency virus type 1 envelope glycoprotein gp120 C5 region (HIV-1 gp120 C5 region)

The Human immunodeficiency virus type 1 envelope glycoprotein gp120 C5 region is the carboxy-terminal conserved segment (C5) of the viral envelope glycoprotein gp120, a major component of the HIV-1 Env trimeric spike responsible for viral entry into host cells[1][6][2][4]. Gp120 is processed from a gp160 precursor and is non-covalently associated with the transmembrane gp41 subunit; together, they form the functional Env complex mediating binding to CD4 and chemokine receptors (CCR5 or CXCR4) on target cells[9][6][8]. The C5 region (residues 489-511 in strain HXB2) is structurally unstructured in aqueous solution but can form a helical motif and directly interfaces with gp41[2][4]. This interaction is critical for the conformational changes required for viral fusion and entry, and thus represents a potential, but challenging, therapeutic target due to its structural dynamics and shielding by other envelope domains[2][4][1][5]. Although the C5 region is less exposed than other Env epitopes, it contributes to envelope trimer stability, is involved in antigenicity modulation, and serves as a site for envelope maturation[1][2][5][6]. Targeting gp120 or Env in general is a major strategy for anti-HIV antibody and entry inhibitor drug development, but the C5 region specifically is not a dominant antibody target due to steric protection and immune evasion strategies of HIV[3][5][1].

Other names

HIV-1 gp120 C5 domainEnvelope glycoprotein gp120 carboxy-terminal regiongp120 C5

Blockade/disruption of gp120-gp41 association (prevents Env-mediated host cell fusion)[2][4] Antibody neutralization (inhibits viral entry by binding to conformational epitopes)[3][5] Other